Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ALLO - Allogene Therapeutics: Promising But Expensive - A Company To Watch

ALLO - Allogene Therapeutics: Promising But Expensive - A Company To Watch

Allogene Therapeutics Inc.
  • ALLO is one of the front runners in the development of allogeneic CAR T cell therapies, with an exciting pipeline of candidates.
  • The share price is currently expensive and appears to ignore risks that clinical trials may not be successful.
  • Valuation should be revisited in the future once further clinical data is available and additional candidates enter clinical trials.
  • ALLO is a company to watch.

For further details see:

Allogene Therapeutics: Promising But Expensive - A Company To Watch
Stock Information
Company Name: Allogene Therapeutics Inc.
Stock Symbol: ALLO
Market: NASDAQ
Website: allogene.com
Menu
ALLO ALLO Quote ALLO Short ALLO News ALLO Articles ALLO Message Board
Get ALLO Alerts

News, Short Squeeze, Breakout and More Instantly...